Motif ID: Elf3
Z-value: 1.138
Transcription factors associated with Elf3:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Elf3 | ENSMUSG00000003051.7 | Elf3 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Elf3 | mm10_v2_chr1_-_135258449_135258472 | 0.65 | 1.3e-09 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 11.4 | GO:2000564 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) CD8-positive, alpha-beta T cell proliferation(GO:0035740) negative regulation of regulatory T cell differentiation(GO:0045590) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 3.7 | 11.1 | GO:0042939 | renal sodium ion transport(GO:0003096) glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 3.1 | 12.4 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 2.9 | 2.9 | GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) |
| 2.4 | 7.3 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 2.3 | 16.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 1.9 | 5.6 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 1.7 | 6.9 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 1.7 | 8.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 1.6 | 4.9 | GO:0046544 | regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) development of secondary male sexual characteristics(GO:0046544) response to interleukin-15(GO:0070672) |
| 1.5 | 8.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 1.4 | 5.4 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) platelet dense granule organization(GO:0060155) |
| 1.3 | 9.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 1.3 | 6.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 1.3 | 6.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 1.3 | 5.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 1.1 | 4.4 | GO:0010046 | arginine biosynthetic process(GO:0006526) response to mycotoxin(GO:0010046) |
| 1.1 | 3.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
| 1.0 | 7.9 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 1.0 | 5.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 1.0 | 2.9 | GO:2000256 | positive regulation of male germ cell proliferation(GO:2000256) |
| 0.9 | 2.7 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.9 | 20.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.9 | 8.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.8 | 3.2 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.8 | 3.2 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.8 | 7.0 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.8 | 2.3 | GO:0031627 | telomeric loop formation(GO:0031627) |
| 0.7 | 2.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.6 | 3.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.6 | 3.7 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.6 | 2.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
| 0.6 | 2.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.6 | 2.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.6 | 5.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.5 | 3.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.5 | 2.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.5 | 2.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 | 2.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) protein localization to ciliary transition zone(GO:1904491) |
| 0.4 | 1.3 | GO:0045014 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) detection of glucose(GO:0051594) |
| 0.4 | 7.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.4 | 11.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.4 | 2.1 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.4 | 14.8 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.4 | 4.3 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.4 | 0.8 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
| 0.4 | 1.9 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.4 | 2.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.4 | 1.8 | GO:0002121 | inter-male aggressive behavior(GO:0002121) response to pheromone(GO:0019236) |
| 0.4 | 1.1 | GO:0046370 | fructose biosynthetic process(GO:0046370) |
| 0.4 | 5.8 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.3 | 4.9 | GO:0030238 | male sex determination(GO:0030238) |
| 0.3 | 13.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.3 | 1.9 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.3 | 1.6 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 0.3 | 2.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.3 | 4.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.3 | 2.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.3 | 12.5 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.3 | 10.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.3 | 0.9 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.3 | 0.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 | 4.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.2 | 4.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 1.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.2 | 0.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 | 2.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.2 | 1.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.2 | 4.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.2 | 1.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.2 | 2.8 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.2 | 0.4 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
| 0.2 | 0.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.2 | 2.1 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 | 2.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 | 1.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 0.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.2 | 1.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 | 0.6 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
| 0.2 | 3.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.2 | 5.9 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.9 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
| 0.1 | 1.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 4.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.4 | GO:0048686 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.1 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 0.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 | 1.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 | 0.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 | 4.1 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
| 0.1 | 0.7 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 1.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.1 | 0.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 | 1.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.1 | 0.9 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.1 | 1.2 | GO:0033622 | integrin activation(GO:0033622) |
| 0.1 | 1.5 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.1 | 0.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.0 | 1.1 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.6 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 | 2.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.0 | 2.8 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
| 0.0 | 1.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.0 | 3.7 | GO:0045580 | regulation of T cell differentiation(GO:0045580) |
| 0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.3 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.0 | 1.8 | GO:0007032 | endosome organization(GO:0007032) |
| 0.0 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.0 | 1.4 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
| 0.0 | 3.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 0.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 2.5 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
| 0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) alveolar secondary septum development(GO:0061144) |
| 0.0 | 1.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 | 0.1 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
| 0.0 | 0.5 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.0 | 3.2 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 | 2.9 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
| 0.0 | 0.1 | GO:0070682 | cytoplasmic sequestering of NF-kappaB(GO:0007253) proteasome regulatory particle assembly(GO:0070682) |
| 0.0 | 0.9 | GO:0051591 | response to cAMP(GO:0051591) |
| 0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.0 | 0.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 | 2.0 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.0 | 1.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.0 | 4.2 | GO:0044772 | mitotic cell cycle phase transition(GO:0044772) |
| 0.0 | 1.6 | GO:0051099 | positive regulation of binding(GO:0051099) |
| 0.0 | 1.0 | GO:0001824 | blastocyst development(GO:0001824) |
| 0.0 | 0.5 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.0 | 8.9 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 2.8 | 11.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 2.6 | 7.9 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
| 2.2 | 11.1 | GO:0032426 | stereocilium tip(GO:0032426) |
| 1.4 | 10.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 1.2 | 5.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 1.0 | 2.9 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.9 | 2.6 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
| 0.8 | 16.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.8 | 8.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.5 | 3.2 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.5 | 1.9 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.5 | 12.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.4 | 11.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.4 | 2.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.3 | 4.4 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.3 | 2.3 | GO:0070187 | telosome(GO:0070187) |
| 0.3 | 4.0 | GO:0031105 | septin complex(GO:0031105) |
| 0.3 | 13.1 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.3 | 5.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.3 | 3.2 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.3 | 3.4 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.3 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.3 | 1.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.3 | 1.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 0.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 5.1 | GO:0005605 | basal lamina(GO:0005605) |
| 0.2 | 1.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.2 | 2.9 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 1.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.2 | 2.8 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 5.1 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.2 | 8.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.2 | 1.9 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 2.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 2.0 | GO:0071203 | WASH complex(GO:0071203) |
| 0.1 | 2.2 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 9.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 10.9 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 7.7 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.1 | 0.8 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 0.1 | 0.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.1 | 0.3 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 2.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 0.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.1 | 1.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 7.2 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 32.5 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 1.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 1.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 7.1 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 1.8 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.0 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.0 | 6.0 | GO:0000776 | kinetochore(GO:0000776) |
| 0.0 | 2.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 1.8 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.0 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 0.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 5.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 2.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 1.9 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 3.2 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 6.8 | GO:0005874 | microtubule(GO:0005874) |
| 0.0 | 1.1 | GO:0005844 | polysome(GO:0005844) |
| 0.0 | 0.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 4.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.0 | 1.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.0 | 8.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 3.2 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 0.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 3.1 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 9.0 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 3.6 | GO:0031012 | extracellular matrix(GO:0031012) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.5 | 16.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 2.4 | 9.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 2.0 | 7.9 | GO:0035877 | death effector domain binding(GO:0035877) |
| 1.8 | 5.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) |
| 1.7 | 6.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 1.4 | 8.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 1.3 | 14.3 | GO:0030957 | Tat protein binding(GO:0030957) |
| 1.2 | 11.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 1.2 | 4.9 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 1.1 | 3.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 1.0 | 17.6 | GO:0017166 | vinculin binding(GO:0017166) |
| 1.0 | 5.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 1.0 | 2.9 | GO:0034190 | very-low-density lipoprotein particle binding(GO:0034189) apolipoprotein receptor binding(GO:0034190) |
| 0.9 | 5.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.8 | 3.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.7 | 11.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.7 | 5.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.7 | 2.9 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
| 0.6 | 2.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.6 | 2.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.6 | 6.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.5 | 5.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.5 | 1.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.5 | 4.4 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.5 | 5.9 | GO:0005522 | profilin binding(GO:0005522) |
| 0.4 | 3.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.4 | 0.8 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.4 | 2.4 | GO:0070728 | leucine binding(GO:0070728) |
| 0.4 | 2.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.4 | 5.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.3 | 6.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.3 | 5.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.3 | 1.9 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.3 | 0.8 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.3 | 4.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.3 | 11.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.3 | 3.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.3 | 2.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.3 | 2.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.2 | 1.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.2 | 1.1 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.2 | 5.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.2 | 0.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.2 | 12.7 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.2 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.2 | 1.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.2 | 3.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.2 | 2.3 | GO:0005537 | mannose binding(GO:0005537) |
| 0.2 | 4.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 2.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 0.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) |
| 0.1 | 3.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 5.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 1.2 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
| 0.1 | 12.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 0.4 | GO:0070976 | TIR domain binding(GO:0070976) |
| 0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 4.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 1.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 0.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.1 | 22.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.1 | 1.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 0.3 | GO:0032564 | dATP binding(GO:0032564) |
| 0.1 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 1.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 0.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
| 0.1 | 2.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 2.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.0 | 0.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 3.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 0.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) acetylcholine binding(GO:0042166) |
| 0.0 | 5.1 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.0 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 10.6 | GO:0005525 | GTP binding(GO:0005525) |
| 0.0 | 0.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
| 0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.0 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 4.6 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 0.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 1.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 1.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.9 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
| 0.0 | 0.6 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
| 0.0 | 0.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.0 | 1.6 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 3.3 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
| 0.0 | 1.6 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.0 | 0.9 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 0.0 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
